Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H19NO4 |
Molecular Weight | 325.3585 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCOC(=O)NC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13
InChI
InChIKey=RQBUXEUMZZQUFY-UHFFFAOYSA-N
InChI=1S/C19H19NO4/c1-2-3-12-23-19(22)20-18(21)17-13-8-4-6-10-15(13)24-16-11-7-5-9-14(16)17/h4-11,17H,2-3,12H2,1H3,(H,20,21,22)
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11606768Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/16645124
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11606768
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/16645124
Ro 67-4853 exhibited activity at all group I of metabotropic glutamate receptors including mGluR1 and mGluR5. It enhances the effects of (S)-DHPG in CA3 neurons. Site-directed mutagenesis revealed that valine at position 757 in transmembrane V of mGluR1 is crucial for the activity of multiple classes of allosteric mGluR1 potentiators. The discovery of selective mGluR1 enhancers opens the possibility for therapeutically relevant positive modulation of family 3 G proteincoupled receptors.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11606768
Curator's Comment: # F. Hoffmann-La Roche Ltd.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3772 |
7.16 null [pEC50] | ||
Target ID: CHEMBL2564 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11606768 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. | 2001 Nov 6 |
|
Function of mGlu1 receptors in the modulation of nociceptive processing in the thalamus. | 2014 Apr |
|
Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1α. | 2014 Jan 17 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11606768
Concentration-response curves for the effect of Ro 67-4853 was generated in CA3 neurons by using 5 uM S-DHPG. The maximum potentiation of the S-DHPG effect by Ro 67-4853 was 637 % of control. Ro 67-4853 was potent in enhancing the effect of S-DHPG with EC50 values of 95 nM.
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9949202
Created by
admin on Sat Dec 16 17:35:53 GMT 2023 , Edited by admin on Sat Dec 16 17:35:53 GMT 2023
|
PRIMARY | |||
|
Ro67-4853
Created by
admin on Sat Dec 16 17:35:53 GMT 2023 , Edited by admin on Sat Dec 16 17:35:53 GMT 2023
|
PRIMARY | |||
|
302841-89-0
Created by
admin on Sat Dec 16 17:35:53 GMT 2023 , Edited by admin on Sat Dec 16 17:35:53 GMT 2023
|
PRIMARY | |||
|
DTXSID70433240
Created by
admin on Sat Dec 16 17:35:53 GMT 2023 , Edited by admin on Sat Dec 16 17:35:53 GMT 2023
|
PRIMARY | |||
|
QM27L9Q3RZ
Created by
admin on Sat Dec 16 17:35:53 GMT 2023 , Edited by admin on Sat Dec 16 17:35:53 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD